Filing Flows › Bolt Biotherapeutics (BOLT) › Q2 2026 › vs Q2 2025
Bolt Biotherapeutics (BOLT) Q2 2026 vs Q2 2025 (year over year)
Bolt Biotherapeutics's revenue fell $1.8M (-100%) from $1.8M in Q2 2025 to $5K in Q2 2026.
Bolt Biotherapeutics, Q2 2026: revenue $5K (-100% year over year), net loss $7.7M, operating cash flow −$6.5M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $5K | $1.8M | −$1.8M | -100% |
| Other income, net | $654K | $649K | $5K | +0.8% |
| Net loss | $7.7M | $8.6M | −$841K | -10% |
| Costs & expenses | $8.4M | $11.0M | −$2.6M | -24% |
| Operating costs | $8.4M | $11.0M | −$2.6M | -24% |
| Research & development | $5.1M | $7.5M | −$2.3M | -31% |
| General & admin | $2.4M | $3.5M | −$1.1M | -31% |
| Operating cash sources | $7.7M | $8.6M | −$841K | -10% |
| Depreciation & amortization | $171K | $347K | −$176K | -51% |
| Share-based compensation | $552K | $625K | −$73K | -12% |
| Working capital & other | $457K | −$2.0M | $2.5M | — |
| Cash used in operations | $6.5M | $9.6M | −$3.1M | -32% |
| Net loss absorbed | $7.7M | $8.6M | −$841K | -10% |
Questions
How much did Bolt Biotherapeutics's revenue grow year over year in Q2 2026?
Bolt Biotherapeutics's revenue fell $1.8M (-100%) from $1.8M in Q2 2025 to $5K in Q2 2026.